SECTION 8 & 15-ACCEPTED AND ACKNOWLEDGED
accepted and acknowledged
on 10 Oct 2024
Last Applicant/ Owned by
Science Based Industries Campus
Petach Tikva
IL
49131
Serial Number
87646713 filed on 16th Oct 2017
Registration Number
5533589 registered on 07th Aug 2018
Correspondent Address
Laurence Rickles
Filing Basis
1. filed as use application
2. use application currently
Disclaimer
NO DATA
COPAXONE 40MG/ML (GLATIRAMER ACETATE INJECTION) THREE TIMES A WEEK RX ONLY
Pharmaceutical preparation for use in human medicine for the treatment of multiple sclerosis containing glatiramer acetate
Classification Information
Class [005]
Pharmaceutical Products
Pharmaceutical preparation for use in human medicine for the treatment of multiple sclerosis containing glatiramer acetate
First Use Date in General
28th Jan 2014
First Use Date in Commerce
28th Jan 2014
Mark Details
Serial Number
No 87646713
Mark Type
No Service/Collective Mark
Attorney Docket Number
No
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Design Code(s)
26.05.21 -
Triangles that are completely or partially shaded
26.11.21 -
Rectangles that are completely or partially shaded
26.11.28 -
Miscellaneous designs with overall rectangular shape
Legal History
| Status Date | Action Taken |
|---|---|
| 10th Oct 2024 | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED |
| 10th Oct 2024 | REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. |
| 10th Oct 2024 | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
| 11th Apr 2024 | TEAS SECTION 8 & 15 RECEIVED |
| 07th Aug 2023 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED |
| 07th Aug 2018 | REGISTERED-PRINCIPAL REGISTER |
| 22nd May 2018 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 22nd May 2018 | PUBLISHED FOR OPPOSITION |
| 02th May 2018 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 18th Apr 2018 | EXAMINER'S AMENDMENT ENTERED |